Search Results
Sort by:
Filter 0
Sort by
14 April 2019 - P1161
Activity of imipenem-relebactam against KPC-positive Enterobacteriaceae isolates from Europe: SMART 2015-2017
14 April 2019 - P1162
Activity of imipenem-relebactam and comparators against Enterobacteriaceae and Pseudomonas aeruginosa from hospitalised patients in Europe - SMART 2017
14 April 2019 - P1175
Antimicrobial activity of cefepime in combination with VNRX-5133 against a global 2018 surveillance collection of clinical isolates
14 April 2019 - P1176
Antimicrobial activity of cefepime in combination with VNRX-5133 against a collection of beta-lactamase-producing Enterobacteriaceae
14 April 2019 - P1164
In vitro activity of imipenem/relebactam and comparator agents against Gram-negative isolates recovered from cancer patients
14 April 2019 - P1174
Antimicrobial activity of high-dose extended infusion cefepime-tazobactam (WCK 4282) tested against Gram-negative organisms collected from medical centres located in Europe and the Asia-Pacific region in 2018
14 April 2019 - P1177
Activity of cefepime/VNRX-5133 and comparators against an Italian nationwide collection of Pseudomonas aeruginosa from respiratory and bloodstream infections
14 April 2019 - P1163
Identification of beta-lactamases in Enterobacteriaceae with varied levels of susceptibility to imipenem/relebactam collected for the SMART surveillance programme, 2015-2017
14 April 2019 - P1184
The novel beta-lactamase inhibitor ETX1317 effectively restores the activity of cefpodoxime against recent global Enterobacteriaceae isolates from urinary tract infections
14 April 2019 - P1185
The novel beta-lactamase inhibitor ETX2514 effectively restores sulbactam activity against recent global Acinetobacter baumannii-calcoaceticus complex clinical isolates
14 April 2019 - P1170
In vitro activity of the extended-spectrum beta-lactamase inhibitor AAI101, in combination with cefepime, against 90 molecularly characterized Enterobacteriaceae isolates expressing a variety of non-beta-lactam resistance mechanisms
14 April 2019 - P1178
VNRX-5133 maintains potent inhibitory activity in engineered NDM-1 variants with increased cefepime hydrolytic efficiency
14 April 2019 - P1186
The susceptibility of global isolates of Acinetobacter baumannii to ETX2514SUL and comparators
14 April 2019 - P1167
Relebactam is efficacious against Pseudomonas aeruginosa and Klebsiella pneumoniae, with sufficient penetration into epithelial lining fluid in a neutropenic mouse model
14 April 2019 - P1169
In vitro activity of meropenem combined with vaborbactam against KPC-producing Enterobacteriaceae in China
14 April 2019 - P1173
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of multidrug-resistant Gram-negative infections
14 April 2019 - P1165
Activity of imipenem-relebactam in clinical isolates of Enterobacteriaceae obtained from a national study in Spain
14 April 2019 - P1171
Antimicrobial activity of cefepime-zidebactam (WCK-5222) against clinical isolates of carbapenem-resistant Enterobacteriaceae collected worldwide in 2018
14 April 2019 - P1172
Cefepime-zidebactam (WCK-5222) activity when tested against Gram-negative organisms isolated from patients hospitalised in Europe and the Asia-Pacific region in 2018
14 April 2019 - P1187
Penicillin-binding protein activity of beta-lactamase inhibitor GT-055
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.